Press Releases

Transgene Presents Promising Pre-Clinical Data on TG1050 to Treat Chronic HBV at EASL 2013

Transgene SA a biopharmaceutical company that develops targeted immunotherapy products to treat major unmet medical needs in cancer and chronic infectious diseases announced pre-clinical data obtained with its novel immunotherapeutic TG1050 to treat chronic hepatitis B infection (CHB)....

Baxter Presents Phase I/II Data Evaluating Lyme Disease Vaccine at NFID Annual Conference on Vaccine Research

Baxter International Inc. today announced Phase I/II data evaluating the safety and immunogenicity of its investigational Lyme disease candidate vaccine during the National Foundation for Infectious Diseases 16th Annual Conference on Vaccine Research in Baltimore, Md. ...

Global regulatory affairs specialist ELC Group receives accreditation to provide readability testing in Romania

ELC GROUP, one of the fastest-growing providers of regulatory affairs consulting services, today announces that the National Agency for Medicines and Medical Devices (NAMMD) has issued ELC Group with accreditation to conduct Readability Testing in Romania. ELC Group...

Metabolix to Present Advances in Biopolymer Technology at ANTEC Conference

Metabolix Inc. an innovation-driven bioscience company focused on delivering sustainable solutions for plastics chemicals and energy today announced that its researchers will make technical presentations at the ANTEC Conference being held April 22-25 in Cincinnati Ohio. ...

Chemspec India 2013 brings together leading suppliers and buyers of fine and speciality chemicals in Mumbai

The ninth edition of Chemspec India - the only dedicated event in India for the fine and speciality chemicals community - concluded successfully at the Bombay Exhibition Centre in Goregaon, Mumbai on April 11 and 12. ...

Novasep discovers explosive properties of Togni reagent II

Novasep, a leading supplier of purification and global manufacturing solutions of synthetic molecules and biomolecules, today announces its R&D team has discovered and characterised the explosive properties of the Togni reagent II and intermediates at the Novasep Leverkusen...

BioFire Submits 510(k) Application to FDA for FilmArray® Blood Culture Identification Test

BioFire Diagnostics Inc. today announced that it has submitted the FilmArray Blood Culture Identification (BCID) Panel to the U.S. Food and Drug Administration (FDA) for 510(k) clearance. The submission comes after the successful completion...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read